Rocket Lab Targets 125 Dollars as It Challenges SpaceX

Rocket Lab is pursuing a larger role in the global space industry as founder and CEO Peter Beck advances plans involving a new rocket, defense contracts, and an acquisition of Iridium Communications. The company's financial performance and launch capabilities could support a share price of $125 in 2027, although execution challenges and shareholder dilution remain significant risks.

Rocket Lab shares traded at $68.21, down 2.22% year to date, despite record second-quarter revenue growth of 62%. According to the company's reported financial results, its backlog reached $2.36 billion, an increase of 137%, while third-quarter revenue guidance stood at $250 million to $265 million.

Analysts surveyed in the source article had an average price target of $106.57, implying approximately 56% upside from the cited share price. Their ratings included four Strong Buy recommendations, 12 Buy ratings, four Hold ratings, and no Sell ratings. Rocket Lab exceeded revenue estimates in each of the previous four quarters, although second-quarter earnings per share of negative $0.08 fell short of the estimated negative $0.0767. The company attributed $8.58 million in costs to its acquisition activity.

Rocket Lab has not yet achieved profitability, making its price-to-sales multiple a key valuation measure. Shares traded at 56.7 times trailing sales, while a $125 share price would raise that multiple to approximately 104 times. The source article cited SpaceX at a 93-times sales multiple and reported that the company generated $7.81 billion in second-quarter revenue, including $648 million from launch services.

Beck has described the proposed Iridium Communications acquisition as a step toward expanding Rocket Lab's role in communications infrastructure. When announcing the transaction, he said it would establish Rocket Lab as “a self-launching, tier-1 space power that will deliver critical communications capability to millions of users worldwide.” Iridium stockholders approved the deal in September, and the transaction is expected to close in mid-2027.

Iridium generated more than $870 million in annual revenue, according to the source article. The acquisition would add an established communications business to Rocket Lab's existing launch and space systems operations, provided the transaction closes as expected.

The development of Neutron, Rocket Lab's reusable medium-lift rocket, is another central factor in the company's growth plans. Its projected starting price of $50 million to $55 million would position it against SpaceX's Falcon 9. CNBC reported that Rocket Lab management expects Neutron boosters to fly 10 to 20 times, supporting a reusable launch model.

Beck expressed confidence in the market for the new vehicle, stating, “Neutron demand is just not a concern.” The rocket's initial launch window was targeted for year-end, but the source article noted that the available window was narrowing. A successful debut and increased launch frequency would be important to the company's competitive plans.

Rocket Lab also has exposure to government defense spending. The fiscal 2027 budget includes $17.9 billion for Golden Dome, while the company already holds an $816 million Space Development Agency contract and a $397 million Flatellite award, according to the source article.

Financial indicators showed improvement in operating performance. Rocket Lab's non-GAAP gross margin increased to 41.5% from 36.9%, while its adjusted EBITDA loss narrowed to $8.8 million from $27.6 million. These changes indicate stronger margins and a smaller adjusted operating loss, although the company remains unprofitable.

Share issuance presents another risk for investors. Rocket Lab raised $1.53 billion by selling stock during the first half of 2026, diluting existing shareholders. The company must also demonstrate that Neutron can enter service and achieve the anticipated launch economics.

Rocket Lab's share price has previously exceeded the $125 target. The source article reported a 52-week trading range of $37.57 to $151 and a five-year gain of 363.7%. Its beta of 2.938 also indicates substantial historical sensitivity to broader market movements, making future returns dependent on execution and market conditions.